Ratings and price targets from Guggenheim analysts, and how many of their targets were reached. Latest call 20 November 2026.
996 Buy, 137 Hold and 4 Sell from 31 October 2025 to 30 October 2026. 441 target raises and 219 cuts.
Targets set above the share price from 2008 to October 2025. Across all firms the figure is 59.2%. How we measure.
Share of the 216 stocks with a sector on AnaChart.
| Analyst | Ratings, 12 mo | Price targets | Stocks | Avg upside | Targets met | Last call |
|---|---|---|---|---|---|---|
| John Difucci | Buy 74%Hold 22%Sell 4% | 863 | 75 | +33.4% | 20 Nov 2026 | |
| Michael Morris | Buy 82%Hold 18%Sell 0% | 725 | 59 | +20.4% | 20 Nov 2026 | |
| Michael Ciarmoli | Buy 67%Hold 33%Sell 0% | 389 | 24 | +37.1% | 20 Nov 2026 | |
| Joseph Osha | Buy 83%Hold 17%Sell 0% | 498 | 62 | +40.4% | 20 Nov 2026 | |
| Simeon Siegel | Buy 66%Hold 34%Sell 0% | 796 | 57 | +24.7% | 19 Nov 2026 | |
| Howard Ma | Buy 87%Hold 13%Sell 0% | 185 | 28 | +52.3% | 19 Nov 2026 | |
| John Heinbockel | Buy 95%Hold 5%Sell 0% | 465 | 42 | +33.3% | 19 Nov 2026 | |
| Michael Schmidt | Buy 96%Hold 4%Sell 0% | 454 | 98 | +81.5% | 19 Nov 2026 | |
| Eddie Hickman | Buy 90%Hold 10%Sell 0% | 45 | 12 | +314.9% | 19 Nov 2026 | |
| Curry Baker | Buy 93%Hold 7%Sell 0% | 612 | 55 | +36.2% | 19 Nov 2026 | |
| Debjit Chattopadhyay | Buy 96%Hold 4%Sell 0% | 406 | 76 | +97.7% | 18 Nov 2026 | |
| Gregory Francfort | Buy 53%Hold 47%Sell 0% | 399 | 39 | +20.5% | 18 Nov 2026 | |
| Yatin Suneja | Buy 96%Hold 4%Sell 0% | 611 | 104 | +126.5% | 16 Nov 2026 | |
| Vamil Divan | Buy 93%Hold 7%Sell 0% | 798 | 81 | +93% | 16 Nov 2026 | |
| Jonathan Lee | Buy 83%Hold 17%Sell 0% | 92 | 17 | +52.8% | 11 Nov 2026 | |
| Subbu Nambi | Buy 97%Hold 3%Sell 0% | 169 | 38 | +21.5% | 10 Nov 2026 | |
| Steven Forbes | Buy 88%Hold 12%Sell 0% | 431 | 31 | +35% | 10 Nov 2026 | |
| Christopher Pasquale | n/a | 37 | 10 | +24% | 9 Nov 2026 | |
| Jason Cassorla | Buy 100%Hold 0%Sell 0% | 160 | 22 | +30.9% | 9 Nov 2026 | |
| Seamus Fernandez | Buy 90%Hold 10%Sell 0% | 344 | 53 | +85.2% | 6 Nov 2026 | |
| Paul Jeng | Buy 100%Hold 0%Sell 0% | 20 | 8 | +115.4% | 4 Nov 2026 | |
| Jacob Smith | Buy 92%Hold 8%Sell 0% | 17 | 5 | +21.2% | 29 Oct 2026 | |
| Bradley Canino | Buy 95%Hold 5%Sell 0% | 58 | 13 | +109.3% | 31 Aug 2026 | |
| Michael Schmitz | n/a | 71 | 24 | +58.4% | 28 Aug 2026 | |
| Robert Drbul | n/a | 65 | 12 | +271.8% | 28 Aug 2026 | |
| Taylor Manley | Buy 88%Hold 12%Sell 0% | 18 | 5 | +31% | 10 Aug 2026 | |
| Jason Smith | Buy 100%Hold 0%Sell 0% | 3 | 2 | n/a | Under 5 targets | 6 Aug 2026 |
| Ray McDonough | Buy 100%Hold 0%Sell 0% | 55 | 14 | +31.5% | 23 Feb 2026 | |
| Frederic Bastien | n/a | 7 | 1 | +43.4% | 8 Feb 2026 |
Analysts with a call in the past 12 months, latest first. Price targets, upside and targets met are each analyst's full Guggenheim record, as on AnaChart stock pages, shown from 5 targets. Updated daily.
| Date | Stock | Analyst | Action | Price target | Rating |
|---|---|---|---|---|---|
| 20 Nov 2026 | PANW | John Difucci | Cut | $34.33 → $0 | Hold |
| 20 Nov 2026 | WMG | Michael Morris | Raised | $36 → $38 | Buy |
| 20 Nov 2026 | WWD | Michael Ciarmoli | Raised | $404 → $410 | Buy |
| 20 Nov 2026 | XE | Joseph Osha | Cut | $57 → $42 | Buy |
| 19 Nov 2026 | DIS | Michael Morris | Raised | $120 → $135 | Buy |
| 19 Nov 2026 | TJX | Simeon Siegel | Cut | $175 → $152 | Buy |
| 19 Nov 2026 | MWH | Joseph Osha | Cut | $50 → $42 | Buy |
| 19 Nov 2026 | P | Howard Ma | Maintained | $215 | Buy |
| 19 Nov 2026 | TGT | John Heinbockel | Raised | $175 → $180 | Buy |
| 19 Nov 2026 | CGON | Michael Schmidt | Target set | $120 | Buy |
| 19 Nov 2026 | HELP | Eddie Hickman | Target set | $49 | Buy |
| 19 Nov 2026 | MSGR | Curry Baker | Raised | $278 → $299 | Buy |
| 18 Nov 2026 | GTN | Curry Baker | Raised | $7 → $8 | Buy |
| 18 Nov 2026 | IONS | Debjit Chattopadhyay | Cut | $80 → $65 | Buy |
| 18 Nov 2026 | SBGI | Curry Baker | Raised | $19 → $20 | Buy |
| 18 Nov 2026 | BROS | Gregory Francfort | Cut | $76 → $62 | Buy |
| 18 Nov 2026 | TRDA | Debjit Chattopadhyay | Cut | $17 → $13 | Buy |
| 18 Nov 2026 | GHRS | Eddie Hickman | Raised | $40 → $46 | Buy |
| 16 Nov 2026 | MTZ | Joseph Osha | Target set | $335 | Buy |
| 16 Nov 2026 | PRAX | Yatin Suneja | Raised | $800 → $1,050 | Buy |
| 16 Nov 2026 | ABSI | Vamil Divan | Cut | $15 → $14 | Buy |
| 16 Nov 2026 | ROIV | Yatin Suneja | Raised | $46 → $48 | Buy |
| 16 Nov 2026 | AVBP | Michael Schmidt | Cut | $30 → $28 | Buy |
| 16 Nov 2026 | JBIO | Vamil Divan | Cut | $47 → $41 | Buy |
| 16 Nov 2026 | ZVRA | Eddie Hickman | Cut | $23 → $18 | Buy |
The most recent target from each analyst on each stock. Updated daily.
Which targets were reached, how fast, and each analyst's Performance Score on every stock they cover.
KeyBankCanaccordB. RileyBenchmarkWedbush
Guggenheim analysts issued 1,137 ratings from 31 October 2025 to 30 October 2026: 996 Buy, 137 Hold and 4 Sell, on 387 stocks.
56.1% of the 3,368 targets its analysts set above the share price from 2008 to October 2025 were reached within 12 months. For those reached, the median wait was 95 days.
By price targets in the past 12 months: Yatin Suneja (86), Curry Baker (84), Subbu Nambi (77).
Healthcare leads with 34% of the stocks it rated in the past 12 months.
Source: AnaChart records of analyst ratings and price targets. 12-month figures run from 31 October 2025 to 30 October 2026. Analysts and latest calls update daily. AnaChart publishes data about analysts' past calls. It is not investment advice.